Search Options Stock News and Analysis from Schaeffer's

Novavax Stock Soars on FDA Approval for COVID Vaccine

https://www.schaeffersresearch.com/content/news/2025/05/19/novavax-stock-soars-on-fda-approval-for-covid-vaccine

5/19/2025 10:33 AM

Biotech stock Novavax Inc (NASDAQ:NVAX) is skyrocketing today, up 26% at $8.48 at last glance, after the U.S. Food & Drug Administration (FDA) approved the company's COVID-19 vaccine. The shot, Nuva...

3 Vaccine Stocks to Watch as Flu Season Approaches

https://www.schaeffersresearch.com/content/analysis/2024/10/16/3-vaccine-stocks-to-watch-as-flu-season-approaches

10/16/2024 2:54 PM

Flu season is almost here, and there is a respiratory syncytial virus (RSV) vaccine update worth monitoring. Earlier today, the Food and Drug Administration (FDA) put a clinical hold on the combinatio...

3 Biotech Stocks to Monitor Right Now

https://www.schaeffersresearch.com/content/news/2024/06/10/3-biotech-stocks-to-monitor-right-now

6/10/2024 3:33 PM

Last week, we profiled biotech exchange-traded fund (ETF) SPDR S&P Biotech ETF (XBI) amid a historically bullish month. Going off of that, we're profiling XBI's three biggest holdings, Novavax Inc (...

Vaccine Stock Explodes After Sanofi Deal

https://www.schaeffersresearch.com/content/news/2024/05/10/vaccine-stock-explodes-after-sanofi-deal

5/10/2024 10:07 AM

Novavax Inc (NASDAQ:NVAX) stock is up 130% to trade at $10.82 today, by far the best stock on the Nasdaq this morning. The drugmaker signed a co-licensing agreement with French pharma giant Sanofi to ...

Novavax Stock on Track for Worst Day Since 2022

https://www.schaeffersresearch.com/content/news/2024/02/28/novavax-stock-on-track-for-worst-day-since-2022

2/28/2024 10:44 AM

Novavax Inc (NASDAQ:NVAX) missed top- and bottom-line estimates for the fourth quarter. The company noted its plans to cut costs, and still narrowed losses from the fourth quarter despite slowing Covi...

PEOPLE ALSO SEARCH FOR

-intraday-options-activity